2,3,4,9-Tetrahydro-1h-carbazol-1-one, 95+%, 250mg

N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-ylamino)phenyl)acetamide, 97%, 1g

H-lle-OAll.TosOH, 95+%, 25g

(E)-3-(5-Nitrothiophen-2-yl)acrylic acid, 97%, 1g

(3aS,8bS)-4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole-7-carbaldehyde, 98%, 1g

Sodium carbonate decahydrate, min. 99%, pa, ISO, 2.5 kg, plastic packaging.

6-(Trifluoromethyl)piperidin-2-one, 98%, 100mg

3-Fluoro-2-iodobenzoic acid, 95.0%, 1g

4,6-Dihydroxyisophthalic acid, 95.0%, 5g

4-Chloro-1-iodo-2-methoxybenzene, 95.0%, 25g

5-[(4-bromophenyl)sulfamoyl]-2-chlorobenzoic acid, 97%, 250mg

4-(4-Ethoxy-phenyl)-5-methyl-thiazol-2-ylamine, 95.0%, 100mg

Reagent reservoirs 175 ml with lid, Non sterile, 10 x 10, 100 pieces